Screening for Atrial Fibrillation With Self Pulse Monitoring

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to determine the efficacy of self-pulse monitoring in detecting atrial fibrillation (AF) in adult patients at increased risk of stroke. The main questions it aims to answer are: - Is self-screening an effective modality for diagnosis of AF? - Are there clinical differences and outcomes for patients who self-screen? Eligible participants will be randomized to either the intervention group or control group. The control group will continue with usual standard of care. Participants randomized to the intervention group will be asked to: - View an online educational video to teach them the appropriate way to manually check their pulse for irregularities. - Manually check their pulse for 30 seconds twice daily for 14 days. - Patients who screen positive for irregularities will be sent a 14-day wearable cardiac monitor to assess for underlying arrhythmias. Researchers will compare the intervention group to the control group to see if there are clinical differences and outcomes.

Clinical Trial Description

Participants will be recruited for this study using MyChart recruiting. Participants meeting inclusion criteria will be invited to participate and can respond "interested" or "decline." Participants who respond interested will complete a brief survey to confirm eligibility prior to consenting. One the participant consents, they will be randomized to the self-pulse check/intervention group or control group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05818592
Study type	Interventional
Source	University of North Carolina, Chapel Hill
Contact
Status	Completed
Phase	N/A
Start date	September 21, 2020
Completion date	May 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06055751` - Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
Recruiting	`NCT04870424` - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement	Phase 3
Active, not recruiting	`NCT05780320` - A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Active, not recruiting	`NCT03866148` - Obstructive Sleep Apnoea and Cardiac Arrhythmias	N/A
Withdrawn	`NCT05656170` - Stellate Ganglion to Prevent Atrial Fibrillation	N/A
Active, not recruiting	`NCT05255224` - PARADISE: Predicting AF After Cardiac Surgery
Recruiting	`NCT04528511` - BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
Recruiting	`NCT04857268` - Diagnostic Validation of Wearable ECG Monitoring Patch, ATP-C120	N/A
Completed	`NCT04118270` - Shared Decision-Making: AFib 2gether Mobile App	N/A
Active, not recruiting	`NCT03345615` - Standard Versus Intensive Monitoring After Myocardial Infarction Looking for Atrial Fibrillation	N/A
Not yet recruiting	`NCT05841056` - Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial	Phase 3
Recruiting	`NCT05149820` - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments	Phase 4
Completed	`NCT03221777` - Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
Not yet recruiting	`NCT03991754` - Prevention of New Onset AF After TAVI (PAF-TAVI Trial)	Phase 3
Completed	`NCT03118518` - STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation	N/A
Completed	`NCT03552588` - High Sensitivity Estimate of the Incidence of Atrial Fibrillation Occurring Transiently With Stress (AFOTS Incidence Study)
Recruiting	`NCT05444335` - Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years	N/A
Terminated	`NCT05950971` - Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation	N/A
Recruiting	`NCT05287191` - MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care	Phase 3
Recruiting	`NCT05300555` - Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery	Phase 4